Cite Filings / MIRM / 0000950170-22-023519
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Mirum Pharmaceuticals, Inc. · Filed 2022-11-09 · Acc 0000950170-22-023519

Documents 1

  • 10-Q Quarterly Report , mirm-20220930.htm

Around this filing

  • 2023-05-04 10-Q Quarterly Report
  • 2022-11-14 4 President and CEO acquired 49 shares (grant or award)
  • 2022-11-14 4 Head of Research & Development acquired 660 shares (grant or award)
  • 2022-11-14 4 Chief Operating Officer acquired 292 shares (grant or award)
  • 2022-11-09 8-K Results of operations
  • 2022-11-09 10-Q Quarterly Report
  • 2022-08-04 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mirm-20220930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…